Drug Development Pipeline
Restore CFTR Function
PTI-808 is a type of CFTR modulator called a potentiator. Potentiators help facilitate the opening of the chloride channel on the cell surface to allow chloride and sodium (salt) to move in and out of the cell.
A phase 1 study to test the safety and tolerability of PTI-808 in healthy adults is underway.
This program is sponsored by Proteostasis Therapeutics. It is being conducted through the Therapeutics Development Network.
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.Learn More